Search Results - "Vishal, N"

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer by Jain, Vikas, Kumar, Hitesh, Anod, Haritha V., Chand, Pallavi, Gupta, N. Vishal, Dey, Surajit, Kesharwani, Siddharth S.

“…Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast cancer (TNBC) in which the three major receptors i.e. estrogen…”
Get full text

Troponin in Heart Failure: Innocent Bystander or Harbinger of Risk? by SHAH, ANAND, RAO, VISHAL N.

Get full text

Identifying and characterizing virus-encoded circular RNAs by Tagawa, Takanobu, Kopardé, Vishal N., Ziegelbauer, Joseph M.

“…•Multiple DNA viruses were found to encode circular RNAs.•Virus-encoded circRNAs have distinct features compared to human circRNAs.•More functional studies are…”
Get full text

Regional adiposity and heart failure with preserved ejection fraction by Rao, Vishal N., Fudim, Marat, Mentz, Robert J., Michos, Erin D., Felker, G. Michael

“…The role of obesity in the pathogenesis of heart failure (HF), and in particular HF with preserved ejection fraction (HFpEF), has drawn significant attention…”
Get full text

Letting go of restraint: Tricuspid valve intervention in heart failure with preserved ejection fraction by Rao, Vishal N., Kozaily, Elie, Tedford, Ryan J.

Get full text

Exposing Faults in the Foundation: Sodium-restrictive Guidance for Ambulatory Heart Failure by KRUKOWSKI, DANIELLE C., RAO, VISHAL N.

Get full text

The vaginal microbiome and preterm birth by Fettweis, Jennifer M., Serrano, Myrna G., Brooks, J. Paul, Edwards, David J., Girerd, Philippe H., Parikh, Hardik I., Huang, Bernice, Arodz, Tom J., Edupuganti, Laahirie, Glascock, Abigail L., Xu, Jie, Jimenez, Nicole R., Vivadelli, Stephany C., Fong, Stephen S., Sheth, Nihar U., Jean, Sophonie, Lee, Vladimir, Bokhari, Yahya A., Lara, Ana M., Mistry, Shreni D., Duckworth, Robert A., Bradley, Steven P., Koparde, Vishal N., Orenda, X. Valentine, Milton, Sarah H., Rozycki, Sarah K., Matveyev, Andrey V., Wright, Michelle L., Huzurbazar, Snehalata V., Jackson, Eugenie M., Smirnova, Ekaterina, Korlach, Jonas, Tsai, Yu-Chih, Dickinson, Molly R., Brooks, Jamie L., Drake, Jennifer I., Chaffin, Donald O., Sexton, Amber L., Gravett, Michael G., Rubens, Craig E., Wijesooriya, N. Romesh, Hendricks-Muñoz, Karen D., Jefferson, Kimberly K., Strauss, Jerome F., Buck, Gregory A.

“…The incidence of preterm birth exceeds 10% worldwide. There are significant disparities in the frequency of preterm birth among populations within countries,…”
Get full text

Discovery of Kaposi’s sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA by Tagawa, Takanobu, Gao, Shaojian, Koparde, Vishal N., Gonzalez, Mileidy, Spouge, John L., Serquiña, Anna P., Lurain, Kathryn, Ramaswami, Ramya, Uldrick, Thomas S., Yarchoan, Robert, Ziegelbauer, Joseph M.

“…Noncoding RNAs have substantial effects in host–virus interactions. Circular RNAs (circRNAs) are novel single-stranded noncoding RNAs which can decoy other…”
Get full text

MeFiT: merging and filtering tool for illumina paired-end reads for 16S rRNA amplicon sequencing by Parikh, Hardik I, Koparde, Vishal N, Bradley, Steven P, Buck, Gregory A, Sheth, Nihar U

“…Recent advances in next-generation sequencing have revolutionized genomic research. 16S rRNA amplicon sequencing using paired-end sequencing on the MiSeq…”
Get full text

A virus-induced circular RNA maintains latent infection of Kaposi's sarcoma herpesvirus by Tagawa, Takanobu, Oh, Daniel, Dremel, Sarah, Mahesh, Guruswamy, Koparde, Vishal N, Duncan, Gerard, Andresson, Thorkell, Ziegelbauer, Joseph M

“…Non-coding RNAs (ncRNAs) play important roles in host-pathogen interactions; oncogenic viruses like Kaposi's sarcoma herpesvirus (KSHV) employ ncRNAs to…”
Get full text

Protective effects of recombinant human golimumab and pentoxifylline in nephrotoxicity induced by cisplatin by Pavitrakar, Vishal N., Mody, Rustom, Ravindran, Selvan

“…In cisplatin‐induced nephrotoxicity, the significant role of activation of inflammatory pathways has been reported earlier. Studies indicate elevated…”
Get full text

Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs by Tagawa, Takanobu, Oh, Daniel, Santos, Jerico, Dremel, Sarah, Mahesh, Guruswamy, Uldrick, Thomas S, Yarchoan, Robert, Kopardé, Vishal N, Ziegelbauer, Joseph M

“…Multiple herpesviruses have been recently found to encode viral circular RNAs. Like cellular circular RNAs, these RNAs lack poly-A tails and their 5' and 3'…”
Get full text

F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer by Kumar, Hitesh, Gupta, N. Vishal, Jain, Rupshee, Madhunapantula, SubbaRao V., Babu, Saravana, Dey, Surajit, Soni, Anshita Gupta, Jain, Vikas

“…[Display omitted] Salinomycin (Sal) is a potent veterinary antibiotic known to offer significant toxicity to the variety of neoplastic cells. Its therapeutic…”
Get full text

Glycemic Control in Hospitalized Stroke Patients: A Review by Patel, Vishal N., Kuo, Emory

“…Purpose of Review The purpose of this review is to discuss clinical trials involving glycemic control in hospitalized stroke patients and to review oral…”
Get full text

Discordance of Pressure and Volume: Potential Implications for Pressure-Guided Remote Monitoring in Heart Failure by Yaranov, Dmitry M., Jefferies, John L., Silver, Marc A., Burkhoff, Daniel, Rao, Vishal N., Fudim, Marat

Get full text

The next frontier in multiple sclerosis therapies: Current advances and evolving targets by Sastri, K. Trideva, Gupta, N. Vishal, Kannan, Anbarasu, Dutta, Suman, Ali M Osmani, Riyaz, V, Balamuralidhara, Ramkishan, A., S, Shanmuganathan

“…Recent advancements in research have significantly enhanced our comprehension of the intricate immune components that contribute to multiple sclerosis (MS)…”
Get full text

Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis by Trideva Sastri, K., Vishal Gupta, N., Kannan, Anbarasu, Balamuralidhara, V., Ramkishan, A.

“…•Impact of miRNA in Multiple Sclerosis.•Nanocarriers mediated miRNA delivery.•Recent advances in miRNA - therapies for managing Multiple Sclerosis. Multiple…”
Get full text

Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem by Rao, Vishal N., Fudim, Marat, Savarese, Gianluigi, Butler, Javed

Get full text

In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction by Rao, Vishal N., Murray, Evan, Butler, Javed, Cooper, Lauren B., Cox, Zachary L., Fiuzat, Mona, Green, Jennifer B., Lindenfeld, JoAnn, McGuire, Darren K., Nassif, Michael E., O’Brien, Cara, Pagidipati, Neha, Sharma, Kavita, Vaduganathan, Muthiah, Vardeny, Orly, Fonarow, Gregg C., Mentz, Robert J., Greene, Stephen J.

“…Sodium-glucose cotransporter-2 inhibitor therapy is well suited for initiation during the heart failure hospitalization, owing to clinical benefits that accrue…”
Get full text

Adiposity and Incident Heart Failure and its Subtypes: MESA (Multi-Ethnic Study of Atherosclerosis) by Rao, Vishal N, Zhao, Di, Allison, Matthew A, Guallar, Eliseo, Sharma, Kavita, Criqui, Michael H, Cushman, Mary, Blumenthal, Roger S, Michos, Erin D

“…This study sought to compare various measures of adiposity with risk for incident hospitalized heart failure (HF) with preserved ejection fraction (HFpEF) and…”
Get full text